Wednesday, July 22, 2015
Frontage, an Exton, Pa.-based CRO, has opened its newest facility in Secaucus, N.J., to expand its clinical research portfolio of services. The new 36,000-square-foot, state-of-the-art, 160-bed clinical research center was part of Frontage’s strategic growth plans to broaden clinical service capabilities and increase capacity.
Frontage Laboratories has appointed Dr. Cheryl Li senior vice president, Global CMC Services. The division offers an integrated service portfolio ranging from dosage form product development, contract manufacturing, pharmaceutical analysis and organic syntheses to CMC strategy consulting. Li’s position is an initial step of Frontage’s corporate strategic expansion in CMC infrastructure to meet growing development needs in novel drugs, generic products and biosimilars.
ICON’s Development Solutions division has named Dr. Daniel Tang general manager, Asia Pacific. Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.